Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Andrew Edmonds

Dentist, General Practice Georgetown, TX Doctor of Dentistry

NPI 1063864965 CMS profile 2656397

4405 Williams Dr Ste 300, Georgetown, TX 78628

Open in the dashboard

General payments

$2,020

63 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Andrew Edmonds of Georgetown, TX is reported in the CMS Open Payments database as having received $2,020 across 63 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Dentist, General Practice profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $209 7
2024 General $562 16
2023 General $587 12
2022 General $79 3
2021 General $209 13
2020 General $158 7
2019 General $216 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andrew Edmonds
  • Dentist, General Practice median
  • Middle half of Dentist, General Practice
  • National median

In program year 2025, general payments to Andrew Edmonds were reported at $209. Among 41,122 Dentist, General Practice profiles paid that year, the median was $75 and the middle half received between $27 and $200.

Show as a table
Year Andrew Edmonds Dentist, General Practice median Middle half National median
2019 $216 $61 $23–$158 $163
2020 $158 $73 $24–$142 $114
2021 $209 $75 $25–$184 $132
2022 $79 $75 $27–$198 $149
2023 $587 $77 $28–$200 $160
2024 $562 $74 $27–$187 $164
2025 $209 $75 $27–$200 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Dentsply Sirona Inc $1,080 28 payments
  2. Align Technology, Inc. $518 23 payments
  3. DENTSPLY IH Inc. $141 1 payment
  4. Keystone Dental Inc. $66 2 payments
  5. Philips Electronics North America Corporation $60 3 payments
  6. Straumann USA LLC $49 1 payment
  7. Solventum Corporation $38 2 payments
  8. Salvin Dental Specialties, Inc. $35 1 payment
  9. Carestream Dental, LLC $16 1 payment
  10. Envista Holdings Corporation $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,954 61 payments
  2. Entertainment $66 2 payments
Products named General payments · program years 2019–2025
  1. WaveOne Gold Conform Fit $771 17 payments
  2. Invisalign $349 19 payments
  3. iTero Element 5D Plus $169 4 payments
  4. ProTaper Next Conform Fit $153 1 payment
  5. Implant Dentistry $141 1 payment
  6. Invisalign First - Comprehensive $140 2 payments
  7. Vivera Retainers $140 2 payments
  8. ProTaper Universal $33 2 payments
  9. CAVITRON $29 1 payment
  10. Whitening Pens $28 1 payment
  11. Other $179 12 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

23

Median for Dentist: 47

Drug cost

$90

Median for Dentist: $159

Branded share of claims

47.8%

Median for Dentist: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 11 $45
Amoxicillin Generic 12 $45

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 110,731 Part D prescribers listed as Dentist; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 3 billing codes

Paid by Medicare

$14,126

Medicare's payments for the services billed

Medicare patients

111

Average age 72

Services billed

341

58 women, 53 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 67%
Arthritis 51%
Ischemic heart disease 30%
Depression 23%
Atrial fibrillation 20%
Diabetes 17%
Osteoporosis 14%
Cancer 13%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

63 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dentist, General Practice in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record